<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR55">
 <label>55.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pithadia</surname>
    <given-names>AB</given-names>
   </name>
   <name>
    <surname>Kakadia</surname>
    <given-names>N</given-names>
   </name>
  </person-group>
  <article-title>Guillain–Barré syndrome (GBS)</article-title>
  <source>Pharmacol Rep.</source>
  <year>2010</year>
  <volume>62</volume>
  <fpage>220</fpage>
  <lpage>232</lpage>
  <pub-id pub-id-type="doi">10.1016/S1734-1140(10)70261-9</pub-id>
  <?supplied-pmid 20508277?>
  <pub-id pub-id-type="pmid">20508277</pub-id>
 </element-citation>
</ref>
